- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03941704
Pulse-based Foods for Alleviation of Negative Consequences of Sedentary Behaviour
Development of Pre-Packaged Pulse-Based Meals to Ameliorate the Negative Health Consequences of Sedentary Behavior
The hypothesis is that consumption of pulse-based foods (i.e. containing chickpeas, lentils, and split peas) during the workday will improve insulin sensitivity, glucose tolerance, blood lipids, body composition, and blood pressure in sedentary office workers.One-hundred office workers from a university campus will participate in a cross-over study where they will be randomized (i.e. assigned by chance) to receive pre-packaged pulse-based lunches and snacks to replace their usual lunches/snacks during the work day OR to continue consuming their usual diets for two months. After the first dietary intervention, they will undergo a 1-month "wash-out" and then participate in two months of the opposite dietary intervention. The main outcome to be assessed is change in glucose and insulin (i.e. blood sugar control) determined during an oral glucose tolerance test. Secondary outcomes include changes in body composition, lipids, and blood pressure.
During the pulse-based diet phases, participants will be supplied with a ready-to-eat lunch and two snacks to eat during each workday. These will contain a total of 150g/d dry weight (250g/d wet weight) pulses
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada, S7N5B2
- College of Kinesiology, University of Saskatchewan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and Women
- 18y or older
- Engaged in >5 hours per day sitting
Exclusion Criteria:
- Diagnosed with diabetes
- taking glucose or lipid-lowering medication
- Regular consumers of pulses (1.5 cups (250g) or greater of pulses per week)
- Engaged in 60 minutes or greater of physical activity per day
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low Glycemic Index
Pulse-based diet
|
Low Glycemic Index
|
|
Active Comparator: Moderate Glycemic Index
Regular diet
|
Moderate Glycemic Index
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insulin sensitivity
Time Frame: Change from baseline to 8 weeks
|
Matsuda Index determined by glucose and insulin response to oral glucose tolerance test
|
Change from baseline to 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glucose area under the curve
Time Frame: Change from baseline to 8 weeks
|
Glucose area under the curve from a 2-hour oral glucose tolerance test
|
Change from baseline to 8 weeks
|
|
Insulin area under the curve
Time Frame: Change from baseline to 8 weeks
|
Insulin area under the curve from a 2-hour oral glucose tolerance test
|
Change from baseline to 8 weeks
|
|
Fasting glucose
Time Frame: Change from baseline to 8 weeks
|
Fasting glucose
|
Change from baseline to 8 weeks
|
|
Fasting insulin
Time Frame: Change from baseline to 8 weeks
|
Fasting insulin
|
Change from baseline to 8 weeks
|
|
Low-density lipoprotein cholesterol
Time Frame: Change from baseline to 8 weeks
|
LDL-C from fasting blood samples
|
Change from baseline to 8 weeks
|
|
High-density lipoprotein cholesterol
Time Frame: Change from baseline to 8 weeks
|
HDL-C from fasting blood samples
|
Change from baseline to 8 weeks
|
|
Total cholesterol
Time Frame: Change from baseline to 8 weeks.
|
Total cholesterol from fasting blood samples
|
Change from baseline to 8 weeks.
|
|
Triglycerides
Time Frame: Change from baseline to 8 weeks
|
Triglycerides from fasting blood samples
|
Change from baseline to 8 weeks
|
|
Waist Girth
Time Frame: Change from baseline to 8 weeks
|
Waist Girth
|
Change from baseline to 8 weeks
|
|
Fat mass
Time Frame: Change from baseline to 8 weeks
|
Fat mass from DXA measurements
|
Change from baseline to 8 weeks
|
|
Lean tissue mass
Time Frame: Change from baseline to 8 weeks
|
Lean tissue mass from DXA measurements
|
Change from baseline to 8 weeks
|
|
Systolic blood pressure
Time Frame: Change from baseline to 8 weeks
|
Systolic blood pressure measured at rest
|
Change from baseline to 8 weeks
|
|
Diastolic blood pressure
Time Frame: Change from baseline to 8 weeks
|
Diastolic blood pressure measured at rest
|
Change from baseline to 8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 609
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Sensitivity
-
Paloma Almeda-ValdésCompleted
-
Société des Produits Nestlé (SPN)CompletedInsulin Sensitivity/ResistanceSwitzerland
-
Cairo UniversityNational Police HospitalActive, not recruitingInsulin Sensitivity/ResistanceEgypt
-
University of Colorado, DenverRecruitingEndothelial Dysfunction | Vascular Stiffness | Insulin Sensitivity/Resistance | TransgenderismUnited States
-
University of Texas, El PasoCompletedInsulin Sensitivity/ResistanceUnited States
-
Centre for Addiction and Mental HealthThe Physicians' Services Incorporated FoundationRecruitingCognition | Healthy Controls | Brain Insulin SensitivityCanada
-
Ingredion IncorporatedUnknownFocus of the Study is Insulin SensitivityUnited States
-
Rigshospitalet, DenmarkUnknownInsulin Sensitivity and Lipid Metabolism
-
Hospices Civils de LyonCisbio BioassaysCompletedInsulin ResistanceFrance
-
Maastricht University Medical CenterCompletedVascular Function | Nitrate | Brain Insulin-sensitivityNetherlands
Clinical Trials on Pulse-based diet
-
University of SaskatchewanAgriculture and Agri-Food Canada; Saskatchewan Pulse GrowersCompletedPolycystic Ovary Syndrome | Metabolic SyndromeCanada
-
University of JordanAbdul Hameed Shoman FoundationCompletedPolycystic Ovary Syndrome | Metabolic SyndromeJordan
-
University of SaskatchewanCompleted
-
University of SaskatchewanRoyal University Hospital FoundationCompletedGlucose IntoleranceCanada
-
USDA, Western Human Nutrition Research CenterUniversity of California, DavisCompleted
-
University of FloridaRecruiting
-
South Dakota State UniversityActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisCompletedProtein-Energy MalnutritionFrance
-
Nordic Institute for Studies of Innovation, Research...University of Agder; The Institute of Transport Economics, Norway; Fredrikstad... and other collaboratorsRecruitingPhysical Inactivity | Health LiteracyNorway
-
University of MinnesotaCompleted